{"id":"W2975900312","doi":"10.1182/blood.v130.suppl_1.1861.1861","title":"A Phase Ib/II Trial of Selinexor Combined with Lenalidomide and Low Dose Dexamethasone in Patients with Relapsed / Refractory Multiple Myeloma","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre; Dalhousie University; Royal Victoria Hospital; University of Toronto; CancerCare Manitoba; Vancouver General Hospital","funders":"","keywords":"Lenalidomide; Tolerability; Neutropenia; Medicine; Regimen; Dexamethasone; Internal medicine; Multiple myeloma; Febrile neutropenia; Oncology; Phases of clinical research; Pomalidomide; Refractory (planetary science); Gastroenterology; Pharmacology; Adverse effect; Clinical trial; Toxicity; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008971459,0.0001189678,0.0001779134,0.00003097158,0.00009495115,0.00001586217,0.00009466519,0.0001049291,0.000003796477],"category_scores_gemma":[0.0001229441,0.00008626853,0.00002470252,0.00002697362,0.00009801298,0.000009120828,0.000055001,0.00008035421,3.729514e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000003407365,"about_ca_system_score_gemma":0.0000354701,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003165678,"about_ca_topic_score_gemma":0.0001096751,"domain_scores_codex":[0.9993587,0.0000335087,0.0001505728,0.0002338033,0.000102805,0.0001206211],"domain_scores_gemma":[0.9992843,0.00001078207,0.0001900244,0.0003968625,0.0000699811,0.00004799563],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4132519,0.008126494,0.132624,0.00007545276,0.0003707767,0.00001790713,0.0002170567,0.000006579089,0.4327235,0.0000114305,0.0001484478,0.01242642],"study_design_scores_gemma":[0.6976804,0.03196093,0.1500744,0.00007793283,0.0001497887,0.00000535497,0.00003290911,0.00002809361,0.1187005,0.00001328589,0.0009732757,0.0003031244],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9994007,0.00003824505,0.0000212792,0.00002043115,0.00006317034,0.0003529146,0.00001796596,0.00000499987,0.00008034646],"genre_scores_gemma":[0.9988254,0.0000142488,0.0009011629,0.00002660914,0.0000803807,0.00001054533,0.00006222823,0.00001881417,0.00006065001],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.314023,"threshold_uncertainty_score":0.3517928,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006399400487065476,"score_gpt":0.2231335860805875,"score_spread":0.216734185593522,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}